Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2000 Dec;23(8):819-25.
doi: 10.1023/a:1026760602577.

Tyrosine hydroxylase deficiency unresponsive to L-dopa treatment with unusual clinical and biochemical presentation

P DE Lonlay  1 , M C Nassogne, A H van Gennip, A C van Cruchten, T Billatte de Villemeur, M Cretz, C Stoll, J M Launay, G C Steenberger-Spante, L P van den Heuvel, R A Wevers, J M Saudubray, N G Abeling
Affiliations
Case Reports

Tyrosine hydroxylase deficiency unresponsive to L-dopa treatment with unusual clinical and biochemical presentation

P DE Lonlay et al. J Inherit Metab Dis. 2000 Dec.

Abstract

Tyrosine hydroxylase (TH) deficiency is generally considered as a cause of the autosomal recessive form of dopa-responsive dystonia, also known as Segawa disease. Clinical hallmarks comprise parkinsonian and other extrapyramidal symptoms. Biochemically the defect leads to the defective synthesis of catecholamines, in particular dopamine. The diagnosis relies on a characteristic pattern of biogenic amine metabolites exclusively in the CSF and can be confirmed by establishing a mutation in the TH gene. Here we present a patient meeting all diagnostic criteria, including a new homozygous mutation (926T > C) with confirmed parental heterozygosity, extrapyramidal symptoms, but atypical other symptoms with periodic neurological episodes observed every 4 days and unresponsive to dopa treatment. The CSF biochemical abnormalities were severe. Uncharacteristically, a strongly abnormal urinary catecholamine metabolite pattern was also consistently observed. The atypical presentation of this patient shows that the clinical and metabolic phenotype of TH deficiency is more variable than formerly thought, and that the condition should no longer be considered as a treatable disorder per se.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Clin Chem. 1990 Oct;36(10):1834-7 - PubMed
    1. Clin Chem. 1998 Sep;44(9):1897-904 - PubMed
    1. Clin Chem. 1999 Dec;45(12):2073-8 - PubMed
    1. J Neurol Neurosurg Psychiatry. 1975 Jul;38(7):666-8 - PubMed
    1. Clin Chim Acta. 1984 Feb 28;137(2):211-26 - PubMed

Publication types

MeSH terms

LinkOut - more resources